Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 1

Status

Recruiting 4Active not recruiting 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Leukemia, Myeloid, Acute 13Myelodysplastic Syndromes 5Advanced Solid Tumors 5Advanced Solid Tumour 4Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Small Cell Lung Carcinoma 2Recurrence 2Multiple Myeloma 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumor 2Advanced Lung Cancer 2Unresectable Locally Recurrent Breast Cancer 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Non-small Lung Cancer 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Multiple Sclerosis 1Metastatic Solid Tumors 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Monocytic, Acute 1Leukemia, Biphenotypic, Acute 1Idiopathic Pulmonary Fibrosis 1Digestive System Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Depression 1

Interventions

Injections 5pembrolizumab 4Pemetrexed 3Carboplatin 3Oxaliplatin 2Leucovorin 2Fluorouracil 2trifluridine tipiracil drug combination 1tislelizumab 1sotorasib 1fludarabine 1WW Domain-Containing Oxidoreductase 1Panitumumab 1Paclitaxel 1Irinotecan 1Immune Checkpoint Inhibitors 1Drug Therapy 1Docetaxel 1Cetuximab 1Bevacizumab 1ASP1570 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Advanced Solid Tumors × Injections × 30 days × Clear all
NCT05906537 2026-05-12

SKB410 for Injection in Solid Tumors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 1 Active not recruiting
54 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06474455 2026-05-11

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

Shanghai Hengrui Pharmaceutical Co., Ltd.

Phase 1/2 Recruiting
156 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT05367635 2026-05-08

A Study of SKB315 in Patients With Advanced Solid Tumors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 1 Recruiting
246 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06428331 2026-05-08

A Study of SKB518 in Patients With Advanced Solid Tumors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 1 Recruiting
150 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT06826040 2026-05-08

SKB445 for Injection in Solid Tumors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 1 Recruiting
126 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡